During open enrollment, choose San Diego's best health care. Get started.

About Fotios Asimakopoulos, MB BChir, PhD

Fotios (Fotis) Asimakopoulos, MB BChir, PhD, is a medical oncologist and hematologist who treats people with plasma cell dyscrasias, also known as plasma cell disorders. His patients may have blood-related diseases such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis, and Waldenstrom's macroglobulinemia (a type of lymphoma).

He offers a variety of highly advanced treatment options, including immunotherapy, cellular therapy, stem cell transplantation, and tumor cell vaccines. Dr. Asimakopoulos is part of the joint UC San Diego Health / Sharp HealthCare Blood and Marrow Transplantation (BMT) Program, one of the largest and most respected BMT units in California, where patients receive care from the same physician throughout all phases of blood cancer treatment. This includes initial consultation and diagnosis, treatment to help achieve remission, care throughout stem cell transplants, and follow-up survivorship care.

As an associate professor in residence of medicine, Dr. Asimakopoulos is involved in training medical students, residents and fellows in hematology and oncology at UC San Diego School of Medicine, where he is the Robert J. Shillman Scholar in Cancer Research. He is an active researcher and his research is funded by the American Cancer Society and the Leukemia and Lymphoma Society.

Prior to joining UC San Diego Health in 2019, Dr. Asimakopoulos was a physician at the University of Wisconsin's Carbone Cancer Center and tenured associate professor at the University of Wisconsin School of Medicine and Public Health in Madison. He also served as scientific director of the University of Wisconsin's Myeloma Study Group.

Dr. Asimakopoulos completed a fellowship in medical oncology and a research fellowship in clinical oncology at Memorial Sloan Kettering Cancer Center in New York. He completed residency training in internal medicine at Harvard Medical School Brigham and Women's Hospital. Dr. Asimakopoulos earned his medical (MB BChir) and doctoral degrees from University of Cambridge, United Kingdom. He also received training in hematology and cancer research as Golda Meir Fellow at the Hebrew University of Jerusalem, Israel.

He is a member of the American Society of Hematology, the International Myeloma Society, the American Association of Immunologists, the American Association for Cancer Research, and the Society for Leukocyte Biology.

Dr. Asimakopoulos speaks fluent Greek and conversational French and Italian.

UC San Diego Health Links

For more information, see Blood Cancers and Cancer Care.

Medical DegreeUniversity of Cambridge, Cambridge, EnglandFellowshipMemorial Sloan Kettering Cancer Center, New York, NYResidencyHarvard Medical School, Brigham and Women's Hospital, Boston, MA
GenderMale
LanguagesGreek
Date Joined Staff2019-11-01
Conditions and Treatments
  • Plasma Cell Dyscrasias
  • Multiple Myeloma
  • Amyloidosis
  • Blood and Marrow Stem Cell Transplantation
  • Cell-Based Immunotherapy
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Waldenstrom's Macroglobulinemia
  • Tumor Cell Vaccines
Cancer

Is My Insurance Accepted?

We accept most major insurance plans at UC San Diego Health. Find out if your insurance is accepted.

News

Health Cancer Man Beach
Cancer Care as Unique as You

Choose UC San Diego Health for truly personalized cancer care at San Diego's only Comprehensive Cancer Center.

Open Payments Program Notification

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.

View Open Payments Data for Dr. Asimakopoulos